Semler Scientific, Inc. Shareholders: Important Legal Update

Semler Scientific, Inc. Shareholder Class Action Lawsuit Notice
The Gross Law Firm announces a significant update for shareholders of Semler Scientific, Inc. (NASDAQ: SMLR). If you acquired shares of SMLR during the specified class period, it is crucial to be informed about the ongoing legal situation surrounding the company.
Understanding the Class Action Lawsuit
There has been an active class period extending from March 10, 2021, to April 15, 2025. Within this timeframe, the lawsuit has received attention due to allegations surrounding misleading statements made by the company. These claims assert that Semler Scientific failed to properly disclose a key investigation by the Department of Justice concerning the False Claims Act.
Key Allegations Raised
According to the complaint, Semler Scientific did not mention an ongoing investigation while discussing possible legal violations. This omission has made public statements misleading, potentially affecting investor confidence and the integrity of investment decisions.
Important Deadlines
Investors should be aware that the deadline to register for participation in the class action is set for October 28, 2025. It is advisable for interested shareholders not to wait in registering, as timely action is vital for potential membership as a lead plaintiff.
Next Steps for Involved Shareholders
Upon registering your shares, you will have access to a portfolio monitoring system that keeps you updated with the latest trends and developments in the case. It's worth noting that there are no associated costs or obligations for participating in this action.
Representation and Recovery
Engaging with the Gross Law Firm, a noted class action firm, provides a significant opportunity for shareholders to seek justice against corporate negligence. The firm is dedicated to protecting investors and ensuring that businesses maintain ethical practices. Past outcomes are non-guaranteed, but efforts will focus on achieving recovery for affected parties.
Contact Information
If you’re a shareholder or are considering joining the case, you can reach out to The Gross Law Firm for guidance:
Mailing Address:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (646) 453-8903
Frequently Asked Questions
What is the class period for the lawsuit regarding Semler Scientific?
The class period extends from March 10, 2021, to April 15, 2025.
What are the main allegations against Semler Scientific?
The allegations suggest that the company failed to disclose a material investigation by the Department of Justice related to the False Claims Act.
When is the deadline for shareholders to register?
The deadline for registration in the class action lawsuit is October 28, 2025.
Are there costs involved in participating in the class action?
No, there are no costs or obligations for shareholders wishing to participate in this case.
Who can I contact for more information on the class action lawsuit?
Shareholders can contact The Gross Law Firm via phone at (646) 453-8903.
About The Author
Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.